The end of compounded versions of weight-loss drugs is near, leaving patients scrambling for alternatives. Some “copycat” ...
Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance.
Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance. Danish ...
The Associated Press on MSN9d
Novo Nordisk cuts Wegovy prices, following Eli Lilly on ZepboundMakers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance. Danish ...
The makers of two popular weight-loss drugs—Wegovy and Zepbound—are cutting prices to make the medications more affordable for people without insurance. Novo Nordisk, the Danish company behind ...
Eli Lilly is offering vials of its weight-loss drug Zepbound to patients at a discount — but only if they skip their ...
Wegovy’s maker, Novo Nordisk, is charging $499 per month for its direct-to-consumer product. Customers can’t get their health insurance to pay for the either Eli Lilly’s Zepbound vials or ...
Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for ...
Makers of Wegovy & Zepbound Cut Prices for Those Without Insurance FRIDAY, March 7, 2025 (HealthDay News) -- The makers of two popular weight-loss drugs — Wegovy and Zepbound — are cutting ...
Last week, Eli Lilly, the maker of Zepbound, also cut prices for its starter dose to $349 per month. Larger doses will now cost $499 per month through the company’s self-pay program.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback